Immunic, Inc.

NasdaqGS:IMUX Stock Report

Market Cap: US$107.2m

Immunic, Inc. Company Information

Immunic, Inc.'s employee growth, exchange listings and data sources

Key Information

  • Name: Immunic, Inc.
  • Ticker: IMUX
  • Exchange: NasdaqGS
  • Founded: 2016
  • Industry: Biotechnology
  • Sector: Pharmaceuticals & Biotech
  • Market Cap: US$107.194m
  • Shares Outstanding: 90.08m
  • Website: https://imux.com

Number of Employees

Location

  • Immunic, Inc.
  • 1200 Avenue of the Americas
  • Suite 200
  • New York
  • New York
  • 10036
  • United States

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
IMUXNasdaqGS (Nasdaq Global Select)YesCommon StockUSUSDApr 2019
10VADB (Deutsche Boerse AG)YesCommon StockDEEURApr 2019

Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2024/11/04 02:22
End of Day Share Price 2024/11/04 00:00
Earnings2024/06/30
Annual Earnings2023/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.